Further support for tTG as the primary target of the small molecule comes from its ability to inhibit cell migration, clonogenic focus formation, and colony formation in soft agar, three cancer cell phenotypes in which tTG has been strongly implicated [4–6, 50–53]. The gene discussed is TGM2; the disease is cancer.